UY26888A1 - COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE - Google Patents

COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE

Info

Publication number
UY26888A1
UY26888A1 UY26888A UY26888A UY26888A1 UY 26888 A1 UY26888 A1 UY 26888A1 UY 26888 A UY26888 A UY 26888A UY 26888 A UY26888 A UY 26888A UY 26888 A1 UY26888 A1 UY 26888A1
Authority
UY
Uruguay
Prior art keywords
compounds
pharmaceutical compositions
heterocyclic
methods
hydroximine
Prior art date
Application number
UY26888A
Other languages
Spanish (es)
Inventor
Wesley Kwan Mung Chong
Rohit Kumar Duvadie
Original Assignee
Agouron Pharamaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharamaceuticals Inc filed Critical Agouron Pharamaceuticals Inc
Priority to UY26888A priority Critical patent/UY26888A1/en
Publication of UY26888A1 publication Critical patent/UY26888A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos con núcleos heterocíclicos-hidroximino-fluoreno que modulan y/o inhiben la actividad de proteínas cinasas. Esto y las composiciones farmacéuticas que los contienen, son capaces de mediar la transducción de la senal de la tirosina cinasa para modular y/o inhibir la proliferación de las células indeseables. Uso terapeútico o prolfiláctico de las composiciones farmacéuticas que contienen dichos compuestos y a los métodos , mediante la administración de una cantidad eficaz de dichos compuestos, para el tratamiento del cáncer y las otras enfermedades asociadas con la angiogénesis y/o proliferación celular indeseable, tales como retinopatía diabética, glaucoma neovascular, artritis reumatoides y soriasisCompounds with heterocyclic-hydroximino-fluorene nuclei that modulate and / or inhibit the activity of protein kinases. This and the pharmaceutical compositions that contain them, are capable of mediating the transduction of the tyrosine kinase signal to modulate and / or inhibit the proliferation of undesirable cells. Therapeutic or prophylactic use of pharmaceutical compositions containing said compounds and methods, by administering an effective amount of said compounds, for the treatment of cancer and other diseases associated with angiogenesis and / or undesirable cell proliferation, such as retinopathy diabetic, neovascular glaucoma, rheumatoid arthritis and psoriasis

UY26888A 2001-08-15 2001-08-15 COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE UY26888A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26888A UY26888A1 (en) 2001-08-15 2001-08-15 COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26888A UY26888A1 (en) 2001-08-15 2001-08-15 COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE

Publications (1)

Publication Number Publication Date
UY26888A1 true UY26888A1 (en) 2002-03-22

Family

ID=38812487

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26888A UY26888A1 (en) 2001-08-15 2001-08-15 COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE

Country Status (1)

Country Link
UY (1) UY26888A1 (en)

Similar Documents

Publication Publication Date Title
DOP2001000120A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE AND INHIBIT THE CELL PROLIFERATION
UY26190A1 (en) TIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEINKINASES AND METHODS FOR THEIR USE
ECSP055858A (en) 2- (1H-INDAZOL-6-ILAMINO) - BENZAMID COMPOUNDS AS INHIBITORS OF USEFUL PROTEINKINASES FOR THE TREATMENT OF OPHTHALMIC DISEASES
UY26231A1 (en) INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF PROTEIN KINASE AND METHOD FOR USE. UNDER LAW 17,164
CO5280047A1 (en) AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THEIR INSTRUCTIONS FOR USE
ECSP066335A (en) INDAZOL 3,5-DISPOSED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION
GT200100061A (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AND METHODS TO INHIBIT PROTEIN KINASES.
PA8550101A1 (en) DERIVATIVES OF BENZAMIDA TIAZOL AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROLIFERATION OF CELLS, AND METHODS FOR USE
AR007855A1 (en) HETERO-CYCLE COMPOUNDS FUSED AS PROTEIN INHIBITORS THYROSINE KINASE, THEIR PREPARATION METHODS, INTERMEDIARIES, USE IN MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0113139A (en) Compounds, their salts, multimeric forms, prodrugs or metabolites, pharmaceutical compositions, method of treating a median disease or dysfunction by inhibiting cdk4 or a cdk4 / cyclin complex, method of treating disease-mediated mammalian condition kinase receptor and method of modulating or inhibiting the activity of a protein kinase receptor
Barbero et al. Expression of functional TRPV 1 receptor in primary culture of canine keratinocytes
PA8525701A1 (en) COMPOUNDS WITH HETEROCICLIC-HYDROXIMINE-FLUORENE NUCLEES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE
UY26888A1 (en) COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE
Zhu et al. Interaction between protein kinase D1 and transient receptor potential V1 in primary sensory neurons is involved in heat hypersensitivity
DOP2003000788A (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES, AND PROCEDURES FOR USE
UY26543A1 (en) INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.
UY26547A1 (en) AMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEINKINASES, AND THEIR METHOD OF USE
ECSP003556A (en) INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF PROTEIN KINASE AND METHODS FOR USE
UY26667A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN KINASES
DOP2004000953A (en) INDAZOL COMPOUNDS 3,5-DISPOSED, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140917